Detection of gammopathy by serum protein electrophoresis for predicting and managing therapy of lymphoproliferative disorder in 911 recipients of liver transplants.

@article{Lemoine2001DetectionOG,
  title={Detection of gammopathy by serum protein electrophoresis for predicting and managing therapy of lymphoproliferative disorder in 911 recipients of liver transplants.},
  author={Antoine Lemoine and P Pham and Daniel Azoulay and Fauzi Saliba and Jean François Emile and Rapha{\"e}l Saffroy and Philippe Broet and Henri Bismuth and Didier Samuel and Brigitte Debuire},
  journal={Blood},
  year={2001},
  volume={98 5},
  pages={1332-8}
}
Monitoring of posttransplantation lymphoproliferative disorder (LPD) is usually based on imaging, which lacks sensitivity. A prospective study in 911 consecutive recipients of liver transplants was conducted to assess the value of gammopathy monitoring by serum protein electrophoresis (SPE) and to compare it with conventional follow-up methods. Patients systematically underwent SPE testing just before transplantation, at least twice during the first year after transplantation, and once a year… CONTINUE READING